Lantheus Holdings (LNTH) Capital Expenditures (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly Capital Expenditures came in at $3.2 million in Q1 2026, down 44.9% year-on-year from $5.9 million in Q1 2025, and down 89.52% on a QoQ basis from $30.8 million in Q4 2025.

Lantheus Holdings (LNTH) Capital Expenditures (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Capital Expenditures data on file, last reported at $3.2 million in Q1 2026.

  • On a quarterly basis, Capital Expenditures fell 44.9% year-over-year to $3.2 million in Q1 2026; TTM through Mar 2026 was $33.5 million, a 724.14% increase from a year earlier, with the FY2025 full-year figure at $36.1 million, up 613.5% from the prior year.
  • Capital Expenditures for Q1 2026 stood at $3.2 million, down from $30.8 million in the prior quarter.
  • Over the last five years, Capital Expenditures for LNTH reached as high as $47.0 million in Q3 2024 and fell as low as -$75.9 million in Q4 2024.
  • Historically, Capital Expenditures has averaged $4.1 million across 5 years, with a median of $5.9 million in 2025.
  • On a YoY basis, Capital Expenditures climbed as much as 438.25% in 2023 and fell as far as 309.12% in 2023.
  • Year by year, Capital Expenditures stood at $18.3 million in 2022, then slumped by 309.12% to -$38.4 million in 2023, then plunged by 97.7% to -$75.9 million in 2024, then surged by 140.57% to $30.8 million in 2025, then tumbled by 89.52% to $3.2 million in 2026.
  • Per Business Quant data, the three most recent Capital Expenditures figures were $3.2 million in Q1 2026, $30.8 million in Q4 2025, and $5.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 168.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 110.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.95 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 99.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 39.90 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 51.00 Mn
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn 3.23 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.23 Mn
Mar 31, 2026 3.23 Mn
Dec 31, 2025 30.77 Mn
Dec 31, 2025 30.77 Mn
Sep 30, 2025 5.32 Mn
Sep 30, 2025 5.32 Mn
Jun 30, 2025 -5.86 Mn
Jun 30, 2025 -5.86 Mn
Mar 31, 2025 5.86 Mn
Mar 31, 2025 5.86 Mn
Dec 31, 2024 -75.85 Mn
Dec 31, 2024 -75.85 Mn
Sep 30, 2024 47.00 Mn
Sep 30, 2024 47.00 Mn
Jun 30, 2024 27.06 Mn
Jun 30, 2024 27.06 Mn
Mar 31, 2024 6.85 Mn
Mar 31, 2024 6.85 Mn
Dec 31, 2023 -38.37 Mn
Dec 31, 2023 -38.37 Mn